標(biāo)題： 1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men 作者：Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名：Clinical Pharmacology in Drug Development 出版日期：2013 期號：No.4 卷號：Vol.2 2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者：Colon-Gonzalez F;Kraft WK. 刊名：Expert Opinion on Drug Metabolism and Toxicology 出版日期：2010 期號：No.10 卷號：Vol.6 3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者：Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名：J Clin Pharmacol 出版日期：2011 卷號：Vol.51 4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者：Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名：Clinical Pharmacology in Drug Development 出版日期：2012 期號：No.3 卷號：Vol.1 5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者：Bernardo Rapoport;Teresa Smit 刊名：Expert Opinion on Drug Safety 6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者：Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名：Br J Clin Pharmacol 出版日期：2017 7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者：Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名：The Journal of Clinical Pharmacology 出版日期：2007 期號：NO.7 卷號：Vol.47 8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者：Ian N Olver 刊名：Ther Clin Risk Manag 出版日期：2008 期號：No.2 卷號：Vol.4 9.Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting 作者：Navari,RM 刊名：Expert Review of Anticancer Therapy 出版日期：2008 期號：No.11 卷號：Vol.8 10.Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting 作者：Rudolph M Navari 刊名：Expert Opinion on Investigational Drugs 出版日期：2007 期號：No.12 卷號：Vol.16 11、Measurement and correlation of tadalafil solubility in five pure solvents at (298.15 to 333.15) 備注：將符合的標(biāo)題的pdf格式上傳，按照投稿時間確認(rèn)稿件，先到先得